Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. Here are some of the latest moves…

Sentrx tapped Chris Metzler as director of quality standards;
Neurochem said g’bye to Phil Calais, who headed global business;
Ambrilia Biopharma hires Phil Calais as its new ceo and president;
InforMedix tapped Bruce Kneeland as vp for pharmacy product leasing;
Rosetta Genomics named Ronen Tamir as exec vp, marketing and communication;
Intranasal Therapeutics named Kathleen Boziwick as vp, commercial development;
Intranasal Therapeutics hired Mike Lusty as vp, pharmaceutical development;
Sangamo BioSciences tapped H. Ward Wolff as exec vp and cfo;
Sunesis named Lesley Stolz as vp corporate and business development;
PHT named Ian McLeod as vp of development;
PHT also promoted Sheila Rocchio to vp of marketing;
Depomed hired Michael Sweeney as vp of product development;
Heidrick & Struggles hired Howard Levine as a principal with its life sciences practice;
Bristol-Myers Squibb adds Alan Lacy to its board;
Bristol-Myers Squibb also severed ties with spokesman Tony Plohoros*.

Hat tip to Pharmaceutical Executive

* We’ve known Tony many years and wish him the best. He is a model spokesman. We hope to hear from him soon.